Cytek Biosciences Return on Assets (ROA) Growth & History (CTKB)
Cytek Biosciences's return on assets (roa) was −13.85% for fiscal 2025.
View full Cytek Biosciences company overviewCytek Biosciences annual return on assets (roa) history
| Fiscal year | Period ended | Return on assets (ROA) | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −13.85% | −12.64 pp |
| 2024 | 2024-12-31 | −1.21% | +1.18 pp |
| 2023 | 2023-12-31 | −2.40% | −2.90 pp |
| 2022 | 2022-12-31 | 0.51% | −0.38 pp |
| 2021 | 2021-12-31 | 0.89% | — |
Cytek Biosciences quarterly return on assets (roa)
| Fiscal quarter | Period ended | Return on assets (ROA) | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −17.14% | −15.83 pp |
| Q1 2026 | 2026-03-31 | −15.89% | −13.58 pp |
| Q4 2025 | 2025-12-31 | −13.85% | −12.64 pp |
| Q3 2025 | 2025-09-30 | −2.60% | −0.59 pp |
| Q2 2025 | 2025-06-30 | −1.31% | +2.17 pp |
| Q1 2025 | 2025-03-31 | −2.31% | −0.04 pp |
| Q4 2024 | 2024-12-31 | −1.21% | +1.18 pp |
| Q3 2024 | 2024-09-30 | −2.01% | +0.73 pp |
| Q2 2024 | 2024-06-30 | −3.48% | −2.33 pp |
| Q1 2024 | 2024-03-31 | −2.26% | −1.84 pp |
| Q4 2023 | 2023-12-31 | −2.40% | −2.90 pp |
| Q3 2023 | 2023-09-30 | −2.74% | −2.23 pp |
| Q2 2023 | 2023-06-30 | −1.15% | −0.43 pp |
| Q1 2023 | 2023-03-31 | −0.43% | −0.65 pp |
| Q4 2022 | 2022-12-31 | 0.51% | — |
| Q3 2022 | 2022-09-30 | −0.50% | — |
| Q2 2022 | 2022-06-30 | −0.72% | — |
| Q1 2022 | 2022-03-31 | 0.22% | — |
Cytek Biosciences return on assets (roa) trends
Between the periods ended 2021-12-31 and 2025-12-31, Cytek Biosciences's return on assets (roa) decreased from 0.89% to −13.85%, a change of −14.73 percentage points. The latest reported quarter, Q2 2026, shows −17.14%.
What return on assets means
Return on assets measures profit relative to the assets used to generate it. It can help compare operating efficiency over time, although normal ROA differs substantially between asset-light and asset-intensive industries.
How return on assets is calculated
TickerStat calculates annual ROA as reported net income divided by average total assets. Quarterly observations use trailing-12-month net income and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cytek Biosciences source filings ↗